Trinity Biotech plc (TRIB) Financials

TRIB Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 105.2 million 177.1 million
Dec. 31, 2025 105.2 million 177.1 million
Sept. 30, 2025 103.7 million 158.4 million
June 30, 2025 99.6 million 149.2 million

TRIB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -1.5 million ?
Dec. 31, 2025 -1.5 million ?
Sept. 30, 2025 -77110 ?
June 30, 2025 -1.7 million ?

TRIB Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -17.5 million
Dec. 31, 2025 -17.5 million
Sept. 30, 2025 -5.1 million
June 30, 2025 -6.0 million

TRIB Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 5.1 million - -
Dec. 31, 2025 5.1 million 16.3 million 10.8 million
Sept. 30, 2025 1.3 million 104.8 million 10.1 million
June 30, 2025 1.5 million 99.5 million 10.6 million

TRIB Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 18.6 million
Dec. 31, 2025 374.2 million
Sept. 30, 2025 18.7 million
June 30, 2025 372.6 million

TRIB Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 11138 1.1 million - -
Dec. 31, 2025 11138 1.1 million 5.4 million -
Sept. 30, 2025 5662 813311 5.8 million -
June 30, 2025 37700 646537 6.7 million -

TRIB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 11.1 million 7.5 million
Dec. 31, 2025 11.1 million 7.5 million
Sept. 30, 2025 14.2 million 8.2 million
June 30, 2025 11.0 million 6.6 million

TRIB

Price: $0.68

52 week price:
0.50
3.44

Payout Ratio Range:
-0.99%
189.42%

Earnings Per Share: -2.00 USD

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Country: Ireland

Volume: 16000

Ebitda: 1.7 million

Market Capitalization: 13.0 million

Links: